In this issue:
Prostate Cancer Foundation advocates to start PSA screening earlier in Black men
Updates to NCCN Clinical Practice Guidelines
Prostate cancer treatment
Prostate cancer early detection
ArteraAI predictive test enables precision medicine in prostate cancer
64Cu-SAR-bisPSMA – new best-in-class PSMA imaging agent?
FDA fast tracks BXCL701 for small cell neuroendocrine prostate cancer
Funding for four relugolix studies
Phase 2 study of PT-112 in metastatic CRPC reached target enrolment
PSMA PET tracer 18F-piflufolastat available in Italy
Determinants of active surveillance uptake in men with low-risk disease
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)